Ms Xiao, a Shanghai healthcare worker in her early thirties, discovered adrenocortical carcinoma during a routine company check-up — a cancer with an incidence of 0.5–2 per million that progresses fast and metastasises early. After surgery and radiotherapy, her doctors pointed her to Ruijin Hospital Hainan, where mitotane, approved abroad but not then available on the mainland, could be prescribed. She became the hospital’s first patient on the drug, and used the zone’s policy allowing patients to take medication home.
在上海一家医疗机构工作的“90 后”肖女士，单位体检时发现肾上腺皮质癌——这种病发病率约百万分之零点五到二，恶性程度高、进展快、易局部转移。手术和放疗后，医生建议她到乐城瑞金海南医院，那里可以开到境外已上市、当时国内还没有的米托坦。她成为该院全国首例用药患者，也用上了“带药离园”的政策。
This page is a short English/Chinese summary of the facts in a patient story published by the Lecheng Administration. Photos are from that publication, credited; a link to the original Chinese article sits at the foot of this page. 本页是对Lecheng Administration发布的一篇患者故事中事实的简短中英摘要。照片取自该发布并标注来源；官方中文原文链接见本页页脚。
